N0N-Invasive JOINT INJECTIONS
Non-Invasive Joint Injections
Non-invasive Injections are newer innovative options for pain management, offering a new approach to comfort. These injections harness the body's innate mechanisms, promoting natural recovery as opposed to masking symptoms. For those suffering from joint pain, this can mean a restoration of function and mobility, a decrease in inflammation, and a significant reduction in discomfort, often without the need for invasive procedures or reliance on long-term medication use. By directly addressing the underlying issues rather than just the symptoms, Non-invasive Injections are redefining the journey toward pain-free living, enabling individuals to return to their everyday activities and enjoy a higher quality of life.
Alternatives to joint replacement
Platelet Injections
Platelet Injections are a newer alternative to treat joint pain due to arthritis or injury. They involve taking a patient’s own blood sample and processing it in a centrifuge to remove red blood cells and white blood cells while concentrating the platelets. A growing body of evidence has shown that Platelets can be as effective or more effective than anti-inflammatory medications or pharma injections.
Platelets are often injected for more mild arthritis.
Growth Factor/Exosome Therapy
Exosome therapy is a new medical treatment that utilizes tiny vesicles called exosomes to deliver therapeutic molecules to specific cells in the body. These exosomes, which are naturally produced by cells, contain a variety of biomolecules including proteins, nucleic acids, and growth factors that can be used to target specific cells and stimulate a desired response.
Exosome therapy is typically injected for moderate arthritis.
Autologous Cells
High concentrations of autologous (patient derived) repair cells can be isolated from a patients own tissue sample including bone marrow or adipose tissue. These cells can be injected to help recover cartilage and stimulate an innate process to provide long term results.
Autologous cells are typically used for moderate to severe arthritis.